1. Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance;Archimbaud;Br. J. Haematol.,1991
2. Interleukin-2 expanded tumour infiltrating lymphocytes in human renal cell carcinoma: isolation, characterization and anti-tumour immunity;Belldegrum;Cancer Res.,1988
3. Cetus interleukin-2 studies in renal cell carcinomas;Bradley,1989
4. Modulation of NK cell activity in patients with solid malignancies by surgical tumour reduction and fibroblast interferon;Flad,1982
5. Characterisation and mechanism of IFN gamma induced protection of human tumour cells from lysis by lymphokine-activated killer cells;Fries;J. Immunol.,1988